Nicole Bender

Good news for all finance professionals. Interesting insights into the ascending demand for CMAs.

5

#knowledge is power…

1

Thank you for this. But maybe you could argue that management support, clear objectives and adequate resources are key success factors for any (substantial) project using any methodology… (see agile, etc…)? So maybe we should focus more on how to actually get those in a resource-scarce and ambiguous environment, rather than treating them as prerequisites ? In real life management attention is scarce, strategic objectives are complex and ambiguous, and resources are limited and have to be shared… Inventors are convinced (that they should get those), innovators are convincing (and mobilize others to create space for their ventures)

1

𝐑𝐞𝐬𝐭𝐫𝐮𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐢𝐬 𝐨𝐧 𝐭𝐡𝐞 𝐫𝐢𝐬𝐞 - 80 percent of respondents note that 𝐫𝐞𝐬𝐭𝐫𝐮𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐢𝐬 𝐛𝐞𝐜𝐨𝐦𝐢𝐧𝐠 𝐢𝐧𝐜𝐫𝐞𝐚𝐬𝐢𝐧𝐠𝐥𝐲 𝐜𝐨𝐦𝐩𝐥𝐞𝐱 Reasons why restructurings are not successful 🔹 𝐒𝐚𝐥𝐞𝐬 𝐩𝐥𝐚𝐧𝐧𝐢𝐧𝐠 𝐧𝐨𝐭 𝐚𝐜𝐡𝐢𝐞𝐯𝐞𝐝 (𝟒𝟏 𝐩𝐞𝐫𝐜𝐞𝐧𝐭) 🔹 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐦𝐨𝐝𝐞𝐥 𝐜𝐨𝐥𝐥𝐚𝐩𝐬𝐞𝐝 (𝟑𝟔 𝐩𝐞𝐫𝐜𝐞𝐧𝐭) 🔹 𝐋𝐚𝐜𝐤 𝐨𝐟 𝐢𝐦𝐩𝐥𝐞𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐭𝐡𝐞 𝐫𝐞𝐬𝐭𝐫𝐮𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐩𝐥𝐚𝐧 (𝟐𝟗 𝐩𝐞𝐫𝐜𝐞𝐧𝐭) 🔹 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐭𝐞𝐚𝐦 (𝟐𝟕 𝐩𝐞𝐫𝐜𝐞𝐧𝐭) 🔹 𝐋𝐚𝐜𝐤 𝐨𝐟 𝐬𝐭𝐚𝐤𝐞𝐡𝐨𝐥𝐝𝐞𝐫 𝐬𝐮𝐩𝐩𝐨𝐫𝐭/𝐚𝐠𝐫𝐞𝐞𝐦𝐞𝐧𝐭 (𝟐𝟓 𝐩𝐞𝐫𝐜𝐞𝐧𝐭) 🔹 𝐔𝐧𝐟𝐨𝐫𝐞𝐬𝐞𝐞𝐧 𝐞𝐱𝐭𝐞𝐫𝐧𝐚𝐥 𝐟𝐚𝐜𝐭𝐨𝐫𝐬(𝟐𝟒 𝐩𝐞𝐫𝐜𝐞𝐧𝐭) 🔹 𝐅𝐢𝐧𝐚𝐧𝐜𝐢𝐧𝐠 𝐞𝐧𝐯𝐢𝐫𝐨𝐧𝐦𝐞𝐧𝐭 (𝟐𝟒 𝐩𝐞𝐫𝐜𝐞𝐧𝐭) I very much share the findings / results of the survey on why restructuring can fail. In my opinion, this emphasizes all the more the need to install a team that independently accompanies the restructuring in a fact-oriented manner and without reservations / or "past" in the company - an essential factor for implementation success! #valuecreation #performanceboost #restructuring #privateequity #structuralcost #targetoperatingmodel

2

⛓️‍💥Broken supply chain? While companies keep managing their supply chain with Excel 🧮 or - more sophisticated ? - with Excel exports from their ERP 🤯 I am not surprised that material flow is not what it is supposed to be. 🤖 AI to the rescue? AI is great and will definitely help us improve performance in many areas. Will it work 100% autonomously, though? I doubt. 💡We need also solutions for people to work smarter Here comes process mining - e.g. using the Celonis inventory management App as a basis - into play. With smart apps which integrate data across multiple sources we can provide 🙋‍♂️people with the information they need in real time to manage the supply chain more effectively📈. Read the latest supply chain pulse check to learn if this insight has already reached today’s supply chain managers. #CPB #SCNO Dr. Julian Theis Sezin Maden

18

Gestärkte Widerstandskraft dank Resilienz: https://lnkd.in/eXtEkp6E Unternehmen, die in unserer von zunehmender Volatilität, Unsicherheit, Komplexität und Ambivalenz (VUCA) geprägten Welt langfristig bestehen wollen, sollten eine hohe Resilienz haben oder diese jetzt aufbauen. Das gilt ebenso für Firmen und Organisationen mit ihren Systemen wie für deren Mitarbeitende, denn beide arbeiten Hand in Hand. Für Unternehmen bedeutet das eine Anpassung von Strukturen und Prozessen. Die Resilienz der Mitarbeitenden lässt sich durch die gezielte Förderung von Schutzfaktoren wie Optimismus, Selbstwirksamkeit und Achtsamkeit unterstützen. Das stärkt die Widerstandskraft sowie den konstruktiven Umgang mit Veränderungen und reduziert die Stressbelastung. 💡Mehr zum Thema Resilienz erfahren Sie am 18. September 2024 an der Nationalen Tagung für betriebliches Gesundheitsmanagement: www.bgm-tagung.ch #GesundheitsförderungSchweiz #Gesundheitsförderung #PublicHealth #PsychischeGesundheit #BetrieblichesGesundheitsmanagement #BGM #NewWork #HomeOffice

3

In my opinion, there are three main reasons why Germany is an attractive investment location for pharmaceutical companies:    🎓 Highly skilled workforce and strong research collaborations  🧬 Large healthcare market  📃 Strong regulatory framework and intellectual property protection    From an economic, medical and scientific point of view, Germany is a strong pharmaceutical, industrial and research location as well as a pioneer in the field of life sciences.    While the German mechanical engineering industry is still in a gloomy mood due to the economic downturn and many medium-sized companies are signaling their intention to invest more abroad – the picture in the pharmaceutical industry is quite different.    A number of investments show the strong commitment of international pharmaceutical companies to Germany as a research location. AbbVie recently announced plans to invest €150 million in a research and development building in Ludwigshafen. The site is designed to sustainably strengthen the company's cutting-edge #research in the fields of #oncology, #neurology and #immunology. Ludwigshafen is AbbVie's second largest research site after Chicago. The focus will be on preparing for the advancement of laboratory automation and digital research.    Furthermore, the Merck Gruppe recently announced plans to invest more than €300 million in the new Merck Life Science research center in #Darmstadt, Germany. Research will focus on solutions for antibody production, #mRNA applications and other products for #biotech #manufacturing.    Strong signals are also coming from the political arena: Minister of Economic Affairs, Robert Habeck, recently spent two days visiting several pharmaceutical sites in three German states and signaled his commitment to improving the conditions for the healthcare industry in Germany.    Together with my teams we are looking forward to investing and support furthermore for an excellent Pharma industry in Germany.    https://lnkd.in/dSpiRrFq  

94

„Doing the right thing even if no-one is looking“ - that is a good definition of #integrity. How to improve your skills to be able to do so is one of many questions to be answered for a good corporate culture. It was a pleasure to share my experience and thoughts about it with some distance in this podcast. Thanks #BCG and Dr. Katharina Hefter for the opportunity. Spotify Link to the podcast below in the comments. #compliance #corporateculture #leadership #crisismanagement

59

2 Kommentare

Tanja Kewes and Handelsblatt reporting today on our 2024 analysis of German DAX Supervisory Boards. The 14th edition of this study by Russell Reynolds Associates shows that while in its first year female representation was at 7% now 40% have been achieved. It goes without saying that an ideal board composition needs to take many other aspects into account, but all considered, DAX Supervisory Boards improved over the years - still leaving some potential to be unlocked.

49

It is an honour that our book is taken up by Michael Köttritsch and Die Presse! If you’re looking for a summer read on change mangement, you might as well grab your copy here: https://lnkd.in/dMgbQNVF

3

Think about Cornelia Siegmann Life Management NLP Beratung

2

1 Kommentar

💛Happiness at Work in Personalwirtschaft���� I’m featured in the July/August edition of one of my favorite HR magazines with a two-page article about Happiness at Work. This issue is all about mental health and mental fitness, which are both directly related to happiness at work. Happy employees are more resilient, less likely to be ill and at lower risk for burn-out and bore-out. Get your copy below! 👇🏻 #mentalhealth #mentalfitness #happinessatwork #resilienz #positivepsychology #bem #betrieblicheeingliederung #krankheitstage #happinessatwork #arbeitsglück

15

2 Kommentare

📣 To my network located in Germany: The Mercer Benefits & Wellbeing Study 2024 is now open for participation! How common are family-friendly benefits such as childcare support, parent-child-offices, paid leave to care for relatives, and so forth in Germany? Share your experiences with us and receive a summary of the results later 🎁 Link to participate in the study (in English or German) below ⬇️

3

Last week was my last day. What began at Baloise on May 2, 2011, now ends after over 13 amazing years. I still remember that May day in 2011 very well. My wife and then very young children gave me a card: “You can do it” was written in large letters. And look at what we've accomplished over the past years! Starting in pricing and later taking responsibility for the Swiss accident and health insurance business, I then returned to the startup world. In 2017, the task was to establish the Corporate Venture Capital Fund for Baloise. Thanks again for the trust of Baloise management at that time. What happened in parallel and then mainly from 2019 onwards, I still can’t fully put into words today. After extensive analysis of various dimensions, Baloise’s top management decided to build an ecosystem in mobility. Incredible team effort kept us on course even during the challenging COVID years. Unfortunately, the changing conditions caught up with us, and Baloise adapted its strategy for 2024. But by 2023, it was already clear to me that both Baloise and I had changed, or rather, developed over the past 13 years. Therefore, it was clear to me by the fall of 2023 that I wanted to move on. To discover something new again, with a wealth of experience, survived adventures, and a completely different network than I had in 2011. Many thanks to all my companions along the way! I can't list you all, as that would exceed the post's limits. But without you, we wouldn’t have been able to celebrate so many successes together! The good thing is, the interaction doesn’t end here and now. As an interim CFO and consultant for startup founder I am already continuing in the ecosystem, and we’ll see what else develops the next months.

224

40 Kommentare

🧭 Navigating through crises determines everyday life of leadership today. What are the important issues that are currently on the agenda of the Management Board and the Supervisory Board? 📓 We surveyed management and supervisory boards of German companies and the result has now been published. With the Corporate Governance Study 2024, we provide insights into four key topics under the motto "Love it, change it or leave it": 🔹 Global Mindset: An Underexposed Element of Diversity in Boards? 🔹 AI: Bits and bots in board work 🔹 Sustainability: between hype, overregulation and real change. 🔹 Engagement: of management and supervisory boards in social and political debates In our study, you can find out how management and supervisory boards currently view these topics and what implications arise from them. ➡️ Download the study now: https://lnkd.in/eCAtRz7B (German only) #CorporateGovernance #Board #executivesearch #KGO

2

Maximilian Schackow and I discussed the keys to unlocking higher efficiency in the industry with sales & service automation strategies. Take a look at the article on #Industrieanzeiger for more insights and let me know what you think! 😉

17

🎥 In the consulting landscape, family businesses are different. Why? Time for a look behind the scenes of Kienbaum. ❗ SMEs are the backbone of our economy. But who or what is actually behind this? 🏢 Although many family businesses are medium-sized companies, not all medium-sized companies are necessarily family businesses. But regardless of how you look at it, the figures stick: A good nine out of ten private companies in Germany belong to the family business category, in which almost 60 percent of private sector employees work. 💡 The fact that family businesses are a special feature in consulting for various reasons prompted us to provide insights into our everyday consulting work in a new documentary. 🎬 The series "The Mittelstand" has set itself the goal of making the importance of medium-sized companies as drivers of innovation and growth for our business location accessible to a broad audience. In addition to companies such as FRoSTA AG or HANSA-FLEX AG, we were accompanied for a year by a film team from the production company Kinescope Film GmbH under the direction of Leonard Geßner. 👉 CLICK HERE FOR THE DOCUMENTARY: https://lnkd.in/esaZzZBS

4

Beirat für Startups #34 Ein Beirat kann grundsätzlich für Startups von großem Vorteil sein. Wie immer, ist es eine Entscheidung, in der es auf den Einzelfall ankommt. 🛣 Einige Gründe hierzu behandele ich wöchentlich in meiner Beitragsreihe : Zum letzten Post der Reihe: https://lnkd.in/dfQsdEuf The Benefits of a Biotech Advisory Board 🧪🔬 As a leader in the biotech industry, I'm excited to share the advantages of having a strong advisory board with expertise in biotechnology. 💡 Cutting-Edge Insights 🔍 An advisory board composed of seasoned biotech professionals can provide invaluable, up-to-date insights into the latest industry trends, technological advancements, and regulatory changes. Their deep knowledge and experience can help guide your strategic decision-making and ensure your company stays ahead of the curve. 🧠 Specialized Expertise 🔬 Biotech advisory board members bring a wealth of specialized expertise across various disciplines, such as drug development, clinical trials, regulatory affairs, and commercialization. Their diverse backgrounds can help you navigate the complex and ever-evolving biotech landscape more effectively, ultimately driving your company's success. 🧪 Networking and Connections 🤝 A well-connected biotech advisory board can open doors to new partnerships, collaborations, and funding opportunities. Their extensive industry networks can introduce you to key stakeholders, potential investors, and strategic partners, expanding your reach and unlocking new avenues for growth. 🌐 Credibility and Validation 👍 Having respected biotech experts on your advisory board can significantly boost your company's credibility and validation in the eyes of investors, regulatory bodies, and potential partners. This can be particularly valuable when seeking funding, navigating the regulatory landscape, or engaging with industry leaders. 🏆 Objective Guidance 🧭 An advisory board provides an outside perspective and objective guidance, which can be invaluable in navigating complex business decisions. Their impartial insights can help you identify blind spots, mitigate risks, and make more informed choices that align with your company's long-term goals. 🧠 By leveraging the expertise and experience of a biotech advisory board, you can unlock a competitive edge, drive innovation, and accelerate your company's growth in the dynamic biotech industry. 🚀 #advisoryboard #board #scaleup

22